An experimental peptide could block Covid-19
MIT chemists are testing a protein fragment that may inhibit coronaviruses’ ability to enter human lung cells.
MIT-based team works on rapid deployment of open-source, low-cost ventilator
Clinical and design considerations will be published online; goal is to support rapid scale-up of device production to alleviate hospital shortages.
MIT-affiliated companies take on Covid-19
A variety of companies with MIT ties are working to address aspects of the Covid-19 pandemic.
A stopgap measure to treat respiratory distress
Repurposing a drug used for blood clots may help Covid-19 patients in danger of respiratory failure, researchers suggest.
Thank you for your patients
An unusual synergy between cancer researchers, clinical centers, and industry leads to promising clinical trials for a new combination therapy for prostate cancer.
MIT community encouraged to respond to request for personal protective equipment
Area hospitals in need of PPE look to university labs and departments for donations.
“Inactive” pill ingredients could raise the dose of your medication
With help from artificial intelligence, researchers identify hidden power of vitamin A and ordinary chewing gum glaze.
SMART announces new method for processing fluid droplets
Microfluidics enables researchers to create unique environment for developing medicine, paving the way for more potent, high-quality drugs.
Covid-19 diagnostic based on MIT technology might be tested on patient samples soon
A variety of MIT research projects could aid efforts to detect and prevent the spread of coronavirus.
Moving beyond “defensive medicine”
Study shows removing liability concerns slightly increases C-section procedures during childbirth.
Mathematical model could lead to better treatment for diabetes
A new model can predict which types of glucose-responsive insulin will work in humans and animals.
A mobile tool for global change
Dimagi’s data-collection platform has helped improve health care for hundreds of millions of people around the world.
How door-to-door canvassing slowed an epidemic
Study finds that in Liberia, volunteers limited damage from Ebola by distributing information within their own communities.
Artificial intelligence yields new antibiotic
A deep-learning model identifies a powerful new drug that can kill many species of antibiotic-resistant bacteria.
What pharmacy students in Ethiopia can do with supply chain education
The MIT Humanitarian Supply Chain lab led a blended supply chain management course with Addis Ababa University.